Status:
COMPLETED
An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy
Lead Sponsor:
University Health Network, Toronto
Conditions:
Acute Myeloid Leukemia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Reduced quality of life, fatigue, and loss of physical function are common in patients getting chemotherapy for acute myeloid leukaemia (AML). The investigators completed a pilot study showing that ex...
Detailed Description
Acute myeloid leukaemia (AML) is a life-threatening malignant blood disorder. Curative treatment requires multiple cycles of intensive chemotherapy. The first cycle, induction, is the most intense and...
Eligibility Criteria
Inclusion
- Is ≥ 18 years old
- Has newly diagnosed AML, or relapsed AML after having been in CR for at least 6 months
- Is initiating induction chemotherapy
- Is ambulatory without need for human assistance
- Has consented to study
- Is medically cleared for participation by the attending physician
Exclusion
- Has another active malignancy
- Has life expectancy \< 1 month, physician determined
- Has significant comorbidity
- Has uncontrolled pain
- Has haemodynamic instability
- Lacks fluency in reading and writing English, and there is no translator available for each visit
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT01446081
Start Date
June 1 2011
End Date
May 1 2013
Last Update
November 25 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9